AG Barr H1 26/27 slides: 8.5% revenue growth despite supply disruption

A.G. Barr reported H1 FY26/27 revenue growth of 8.5% to £247.4 million and profit before tax growth of 2.6% to £36.1 million, while maintaining a 15.0% operating margin. Temporary supply-chain issues cost an estimated £10 million of sales, contributed to a 140bp gross-margin decline to 40.8%, and coincided with net bank debt rising to £47.0 million from net cash of £41.3 million a year earlier after acquisitions and £23.4 million of capex. Management said disruptions are resolved, raised the interim dividend 11% to 3.82p, and reaffirmed FY guidance for roughly 10% revenue growth and £71-72 million of PBT, though shares slipped 0.35% following the update.

Analysis

BAG's near-term equity setup hinges less on top-line recovery than on cash-conversion credibility. The combination of inventory build, acquisition spending and elevated capex has shifted the balance-sheet narrative from net-cash compounder to execution story; if H2 working-capital release fails to materialize, the market is likely to penalize the stock despite delivery of profit guidance. Conversely, restoration of cash generation and exit net debt within the guided £10-20m range would remove the principal reason for a discount versus higher-quality beverage peers over the next 1-3 months.

The more valuable embedded option is manufacturing insourcing. Bringing Boost categories in-house should replace third-party conversion costs with fixed-cost absorption, so incremental volumes can create margin upside after FY27 rather than merely sustain the current margin band. That also raises downside operating leverage: weak consumer demand or a delayed Milton Keynes ramp would leave BAG carrying higher depreciation and capacity costs without the expected throughput. Fentimans/Frobishers synergy claims should be treated as unproven until gross margin stabilizes and acquired-brand growth becomes visible in reported numbers.

Competitive risk is concentrated in the value proposition. BAG's price gaps versus MNST, KO and Lucozade-type branded alternatives provide room for selective realization, but also indicate that volume growth has been partly purchased through affordability. A UK consumer slowdown could favor BAG's value brands initially, while sustained input-cost inflation would force a choice between margin protection and preserving that relative-price advantage. The October 2027 deposit-return rollout is a sector-wide friction, but BAG's broad SKU base and smaller operating scale make labeling, inventory and working-capital disruption more material than for KO bottlers.

Consensus appears to be treating the operational disruption as a one-off and the capex peak as self-liquidating. That may be directionally right, but the stock needs evidence, not reassurance: H2 must show both availability recovery and conversion of revenue into cash. The asymmetric catalyst is an upgrade only if management demonstrates that supply normalization produces above-guidance profit or a clear FY28 margin bridge; merely meeting reaffirmed guidance is unlikely to rerate the shares.

Key Decisions for Investors

• Initiate a small BAG long only on confirmation of H2 cash recovery—specifically, evidence that year-end net debt can reach the £10-20m guide—rather than chasing the results-day move. Target a 6-12 month rerating on de-risked capex and synergy delivery; exit if net debt remains materially above guidance or operating margin falls below the 14-16% framework.
• For a cleaner relative-value expression, consider long BAG / short MNST over 6-12 months, sized modestly. BAG offers potential margin inflection from insourcing while MNST is more exposed to premium-energy category normalization; invalidate if Boost's retail momentum decelerates materially or BAG's manufacturing ramp slips beyond FY28.
• Do not add exposure ahead of the next trading update solely on stated supply-chain normalization. Set an alert for reported H2 gross-margin progression and working-capital release: flat-to-down gross margin alongside continued inventory absorption would indicate that the disruption was not transitory and argues for avoiding BAG.
• Monitor TSCO and other UK grocers into the deposit-return implementation cycle rather than treating DRS as a BAG-only issue. Retailer collection logistics and promotional resets could temporarily pressure beverage sell-through in FY28; a broad category-volume slowdown would weaken BAG's fixed-cost absorption thesis before it becomes visible in earnings.